These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36994214)

  • 1. Indo-cyanine green administration to identify loss of lymph after axillary lymph node dissection.
    Roman MM; Delrue P; Karler C; Del Marmol V; Bourgeois P
    Front Oncol; 2023; 13():1045495. PubMed ID: 36994214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Temporal Variation in ICG Administration on Axillary Node Identification During Reverse Mapping Procedures.
    Roman MM; Nogaret JM; Veys I; Delrue P; Eddy C; Karler C; Marmol VD; Bourgeois P
    Chirurgia (Bucur); 2022 Jun; 117(3):305-311. PubMed ID: 35792541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Near-Infrared Fluorescence Imaging of Breast Cancer and Axillary Lymph Nodes After Intravenous Injection of Free Indocyanine Green.
    Bourgeois P; Veys I; Noterman D; De Neubourg F; Chintinne M; Vankerckhove S; Nogaret JM
    Front Oncol; 2021; 11():602906. PubMed ID: 33767980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple mapping for axillary staging after neoadjuvant therapy: Axillary reverse mapping with indocyanine green and dual agent sentinel lymph node biopsy.
    Tasdoven I; Balbaloglu H; Erdemir RU; Bahadir B; Guldeniz Karadeniz C
    Medicine (Baltimore); 2022 Dec; 101(52):e32545. PubMed ID: 36596061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic value of optical imaging combined with indocyanine green-guided sentinel lymph node biopsy in gastric cancer: a meta-analysis].
    He MF; Jiang ZW; Hao ZW; An J; Zhai J; Shen JK
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1196-1204. PubMed ID: 31874538
    [No Abstract]   [Full Text] [Related]  

  • 6. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the result of completion axillary lymph node dissection influence the recommendation for adjuvant treatment in sentinel lymph node-positive patients?
    Sávolt A; Polgár C; Musonda P; Mátrai Z; Rényi-Vámos F; Tóth L; Kásler M; Péley G
    Clin Breast Cancer; 2013 Oct; 13(5):364-70. PubMed ID: 23773380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence.
    Murawa D; Hirche C; Dresel S; Hünerbein M
    Br J Surg; 2009 Nov; 96(11):1289-94. PubMed ID: 19847873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary Axillary Management in cT1-2N0 Breast Cancer with One or Two Positive Sentinel Lymph Nodes: Factors Associated with Completion Axillary Lymph Node Dissection Within the National Cancer Database.
    Stafford AP; Hoskin TL; Day CN; Sanders SB; Boughey JC
    Ann Surg Oncol; 2022 Aug; 29(8):4740-4749. PubMed ID: 35451727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyzing non-sentinel axillary metastases in patients with T3-T4 cN0 early breast cancer and tumor-involved sentinel lymph nodes undergoing breast-conserving therapy or mastectomy.
    Riedel F; Heil J; Feisst M; Moderow M; von Au A; Domschke C; Michel L; Schaefgen B; Golatta M; Hennigs A
    Breast Cancer Res Treat; 2020 Nov; 184(2):627-636. PubMed ID: 32816190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer.
    Hirche C; Murawa D; Mohr Z; Kneif S; Hünerbein M
    Breast Cancer Res Treat; 2010 Jun; 121(2):373-8. PubMed ID: 20140704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Indocyanine Green Tracer-Guided Lymph Node Dissection During Laparoscopic Radical Gastrectomy in Patients With Gastric Cancer: A Randomized Clinical Trial.
    Chen QY; Xie JW; Zhong Q; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng HL; Li P; Zheng CH; Huang CM
    JAMA Surg; 2020 Apr; 155(4):300-311. PubMed ID: 32101269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
    Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
    Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subsequent axillary surgery after sentinel lymph node biopsy: results from the BreastSurgANZ Quality Audit 2006-2010.
    Chong C; Walters D; de Silva P; Taylor C; Spillane A; Kollias J; Pyke C; Campbell I; Maddern G
    Breast; 2013 Dec; 22(6):1215-9. PubMed ID: 24157405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes.
    Foster D; Choy N; Porter C; Ahmed S; Wapnir I
    J Surg Oncol; 2018 Mar; 117(3):336-340. PubMed ID: 29228459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of near-infrared or fluorescent indocyanine green guided sentinel lymph node mapping in gastric cancer: A systematic review and meta-analysis.
    He M; Jiang Z; Wang C; Hao Z; An J; Shen J
    J Surg Oncol; 2018 Dec; 118(8):1243-1256. PubMed ID: 30380146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?
    Hennigs A; Köpke M; Feißt M; Riedel F; Rezai M; Nitz U; Moderow M; Golatta M; Sohn C; Schneeweiss A; Heil J
    Breast Cancer Res Treat; 2019 Jan; 173(2):429-438. PubMed ID: 30315437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Women Could Avoid Axillary Lymph Node Dissection by Choosing Breast-Conserving Therapy Instead of Mastectomy.
    Vane MLG; Hunter-Squires J; Kim S; Smidt ML; Giuliano AE
    Ann Surg Oncol; 2021 May; 28(5):2522-2528. PubMed ID: 33586070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locoregional Management of the Axilla in Mastectomy Patients with One or Two Positive Sentinel Nodes: The Role of Intraoperative Pathology.
    Davis J; Boughey JC; Hoskin TL; Day CN; Cheville JC; Piltin MA; Hieken TJ
    Clin Breast Cancer; 2021 Oct; 21(5):458-465. PubMed ID: 33839043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the indocyanine green fluorescence and blue dye methods in detection of sentinel lymph nodes in early-stage breast cancer.
    Sugie T; Sawada T; Tagaya N; Kinoshita T; Yamagami K; Suwa H; Ikeda T; Yoshimura K; Niimi M; Shimizu A; Toi M
    Ann Surg Oncol; 2013 Jul; 20(7):2213-8. PubMed ID: 23429938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.